Leonie Smeenk

6PUBLICATIONS
79CO-AUTHORS
Medical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 08, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro

|Mar 31, 2025
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Etienne Sollier, Anna Riedel, Umut H Toprak

|May 15, 2024
Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2.

Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro

|Sep 12, 2022
EVI1 drives leukemogenesis through aberrant ERG activation.

Johannes Schmoellerl, Inês A M Barbosa, Martina Minnich

|Sep 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.

Sophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren

|May 13, 2021
Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.

Leonie Smeenk, Sophie Ottema, Roger Mulet-Lazaro

Pageof 1